AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

  • AI Partnerships Drive AMD Rally: AMD recently inked blockbuster AI deals – a multi-year pact to supply OpenAI with GPUs powering 6 gigawatts of compute, and an Oracle Cloud agreement to deploy 50,000 of AMD’s next-generation Instinct GPUs [1] [2]. These contracts are projected to generate “tens of billions” in annual revenue and over $100 billion cumulatively in new sales [3] [4]. The news sparked a massive market reaction: on Oct. 6 AMD shares surged 34% in one day (the biggest gain since 2016) [5], adding roughly $80 billion to its market value.
  • Record Stock Performance: AMD stock has climbed roughly 80–95% year-to-date (as of late Oct. 2025), far outpacing peers [6] [7]. It briefly hit all-time highs in mid-October (around $238 per share [8]) before settling near ~$235 by Oct. 23 [9] [10]. For comparison, Intel shares trade near $38 (up ~85% YTD) [11] and NVIDIA (still dominant in AI GPUs) around $180. AMD’s ~$380 billion market cap now rivals Intel’s and sits behind only Nvidia (now a ~$4T company) [12]. Market observers note this rally is “extraordinary” – the Philadelphia Semiconductor Index is up only ~32% in 2025, so AMD’s gain stands out among chipmakers [13] [14].
  • Bullish Analyst Sentiment: Wall Street has grown very optimistic. Major firms have raised price targets into the mid-$200s to $300 range [15]. For example, Bank of America’s Vivek Arya hiked his 12-month target to $300 [16], Jefferies and Wolfe Research each raised targets to $300, and HSBC’s is $310 [17]. Overall about 60–65% of analysts rate AMD a “Buy,” compared to ~50% earlier in the year [18] [19]. Morgan Stanley recently bumped its 2027 revenue forecast to $51.2 billion (from $44.2B) on an improving datacenter outlook [20]. Even traditionally cautious houses (Goldman, Citigroup) have turned neutral-on-AMD after the AI agreements, while more bullish ones (Wedbush, Stifel) boosted targets – Wedbush raised its price target to $270 citing the AI deal thesis [21].
  • Strong Financial Results & Guidance: AMD’s latest earnings exceeded expectations. Q2 2025 revenue was $7.69 billion (up +32% YoY) and adjusted EPS $0.48 [22]. CEO Lisa Su noted product rollouts have contributed to the gain. The company guided Q3 2025 revenue to about $8.7 billion (up ~20% YoY) [23], with full-year 2025 sales now targeted near $33 billion [24]. CFO Jean Hu said the OpenAI agreement “should deliver tens of billions of dollars in revenue” and be “highly accretive” to future earnings [25]. Despite strong demand, growth is partly limited by U.S. export curbs: AMD expects a ~$1.5 billion hit to 2025 sales from restrictions on AI chip shipments to China [26].
  • Intel and NVIDIA Context: AMD’s rise comes against fierce competition. Nvidia remains the undisputed AI leader, commanding roughly 90–94% of the data-center GPU market [27]. In Nvidia’s last quarter, its data-center revenue jumped 73% to $39.1 billion [28], dwarfing AMD’s $3.2B (14% growth) for the same period. Nvidia’s CEO Jensen Huang has reacted to the AMD-OpenAI deal as “imaginative” and “surprising,” quipping that giving up 10% of AMD (through the OpenAI warrant) was “clever, I guess” [29]. Huang nonetheless praised AMD as “a really good company” that Nvidia takes “very seriously” [30], implying Nvidia will closely watch AMD’s execution. Intel is also ramping up AI: in mid-October it unveiled a new “Crescent Island” data-center AI chip for 2026 [31] [32] and secured major funding (the U.S. government’s CHIPS stake plus $7B from Nvidia/SoftBank) to boost its data-center focus [33]. In this context, AMD is pitching its GPUs, EPYC CPUs and new Helios AI server racks as an “open” alternative to Nvidia’s proprietary systems [34] [35].
  • Valuation & Risks: AMD’s rally has stretched valuations. TS2.Tech notes AMD now trades around 40× expected 2026 earnings (its trailing P/E exceeds 100×) [36] – rich even against Nvidia (~30×) [37]. Simply Wall St analysts flag that much of the growth is already baked in: they warn of “downside risk if growth projections prove too bullish or competition and regulatory challenges weigh on performance” [38]. In other words, at current price levels AMD’s multiples leave “little room for error” if orders disappoint or new products underperform [39] [40]. A few firms (Goldman Sachs, Citi) maintain neutral ratings with 12-mo targets near $210 [41] [42], citing high expectations. The stock’s elevated valuation means any broader tech selloff or stumble in AI demand could trigger profit-taking.
  • Outlook & Forecasts: Looking ahead, analysts paint both bullish and cautious scenarios. In the short term, AMD’s momentum may test up against market volatility – it must sustain high growth (and meet Nov. 4 Q3 results) to justify today’s levels [43] [44]. Bank of America, for example, forecasts AMD on a “conservative path to $10+” annual EPS by 2027 based on these AI ramps [45] – which would imply a three- to four-fold share-price gain. Wedbush’s thesis is that each gigawatt of AI capacity could mean roughly $20 billion in AMD sales [46]. If AMD can achieve production of the MI450/MI400X GPUs and ramp deals with hyperscalers (OpenAI, Oracle, Meta, etc.), many analysts believe its long-term growth will be substantial. Short-term, targets range mostly in the $240–$300 area [47] [48]. However, bears point out that if AMD fails to significantly dent NVIDIA’s AI dominance or if macro/regulatory headwinds emerge, the stock could retreat toward the $180–$210 range cited by some fair-value models [49] [50].

In summary, AMD’s recent AI-driven surge has been fueled by heavyweight partnerships and robust demand, earning plaudits from executives and analysts alike. But the stock now sits at lofty valuations. Investors will be watching closely whether AMD can translate its new AI wins into sustained growth – success could justify prices well above today’s $235, while any misstep might curb the rally. As one analyst quipped, AMD is striving to be the “open, secure, and scalable” AI platform versus Nvidia’s closed box [51]. Whether Wall Street’s bullish forecasts come true will depend on that bet paying off in the years ahead.

Sources: News and analyses from Reuters [52] [53], TS2.Tech [54] [55], CNBC/Benzinga [56], Fox Business [57], Investing.com [58], and Simply Wall St [59]. All data as of Oct. 24, 2025.

GET IN EARLY! I'm Buying This AI Chip Stock (Even Over NVIDIA Stock)

References

1. www.reuters.com, 2. www.reuters.com, 3. www.reuters.com, 4. ts2.tech, 5. www.reuters.com, 6. ts2.tech, 7. www.benzinga.com, 8. ts2.tech, 9. ts2.tech, 10. ts2.tech, 11. ts2.tech, 12. ts2.tech, 13. ts2.tech, 14. ts2.tech, 15. ts2.tech, 16. ts2.tech, 17. ts2.tech, 18. ts2.tech, 19. ts2.tech, 20. www.investing.com, 21. ts2.tech, 22. www.reuters.com, 23. ts2.tech, 24. ts2.tech, 25. ts2.tech, 26. www.reuters.com, 27. ts2.tech, 28. www.reuters.com, 29. www.benzinga.com, 30. www.benzinga.com, 31. ts2.tech, 32. ts2.tech, 33. ts2.tech, 34. ts2.tech, 35. www.reuters.com, 36. ts2.tech, 37. ts2.tech, 38. simplywall.st, 39. ts2.tech, 40. simplywall.st, 41. ts2.tech, 42. ts2.tech, 43. ts2.tech, 44. ts2.tech, 45. ts2.tech, 46. ts2.tech, 47. ts2.tech, 48. ts2.tech, 49. simplywall.st, 50. ts2.tech, 51. ts2.tech, 52. www.reuters.com, 53. www.reuters.com, 54. ts2.tech, 55. ts2.tech, 56. www.benzinga.com, 57. www.foxbusiness.com, 58. www.investing.com, 59. simplywall.st

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?
Previous Story

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside
Next Story

Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

Stock Market Today

  • Best Stocks to Invest $50,000 in Right Now: Alphabet and Dominion Energy Lead the Pack
    October 24, 2025, 6:00 AM EDT. Investors weighing where to place $50,000 should balance growth potential with defensive income. The piece flags Alphabet as an AI pioneer with growth drivers from Google Cloud, Waymo, and Quantum AI, positioning it to benefit from surging AI adoption and cloud demand. Dominion Energy is presented as a defensive beacon with a solid dividend and reasonable valuation (forward P/E around 17), plus exposure to rapid data-center energy needs in Virginia and nearby markets. The author notes that while no stock guarantees positive returns, these picks offer upside tied to AI leadership and steady income for risk-managed exposure. A third stock is teased but not detailed in the excerpt.
  • Darling Ingredients Stock Remains Resilient Amid Challenges (NYSE: DAR)
    October 24, 2025, 6:14 AM EDT. Darling Ingredients Corp. (DAR) on the NYSE is highlighted as remaining resilient despite macro and industry headwinds. The article, penned by Daniel from Crude Value Insights, applies a value-oriented contrarian lens-rooted in Benjamin Graham's principles-to assess whether DAR trades meaningfully below its intrinsic value. While the piece reflects the author's personal opinions and emphasizes disciplined cash-flow analysis, it also notes standard disclosures: no current stock, option, or derivatives positions and no compensation tied to the article beyond Seeking Alpha. Readers are reminded that performance and valuation depend on factors like cash flow, margins, and long-term growth catalysts, with a focus on how patience and disciplined evaluation can support a thesis for DAR in a challenging environment.
  • Rep. Lisa C. McClain Sells Unilever Shares; Insider Trades Highlight Diversified Stock Moves
    October 24, 2025, 6:28 AM EDT. Representative Lisa C. McClain (R-Michigan) disclosed selling between $1,001 and $15,000 of Unilever PLC (NYSE: UL) on September 25 in the CHARLES SCHWAB BROKERAGE ACCOUNT 924. The filing also lists other 9/25/2025 trades: purchases of FMC, Darden Restaurants, ASML, KVUE, SAP, MGPI; and sales of MMSI, BBT, BTI. UL opened at $62.28 with 50-day MA $61.58 and 200-day MA $61.75. Key metrics: market cap ~$152.8B, P/E 17.85, P/E/G 4.68, beta 0.40. UL raised its quarterly dividend to $0.5175 per share (annualized $2.07, yield 3.3%). Analysts' ratings vary; consensus Moderate Buy with a $73 target.
  • Harmony Biosciences Surges 12.7% on Strong Q3 Outlook; Raises 2025 Revenue Guidance
    October 24, 2025, 6:31 AM EDT. Harmony Biosciences Holdings, Inc. (HRMY) jumped 12.7% in the latest session on strong volume, closing at $29.60. The move came after robust preliminary Q3 2025 results, with Wakix (pitolisant) revenues around $239 million, up 29% year over year. The company raised its 2025 revenue guidance to $845-$865 million from $820-$860 million. Ahead of its Q3 2025 report on Nov. 4, consensus calls for EPS of $0.83 and revenue around $221 million, representing YoY gains of roughly 5% and 19%, respectively. The stock carries a Zacks Rank #3 (Hold). Investors will watch for any earnings estimate revisions that could sustain the move, and whether momentum carries into the next quarter.
  • Nvidia 2026 Outlook: AI Data-Center Demand Could Drive 42% CAGR
    October 24, 2025, 6:32 AM EDT. Nvidia has ridden the AI wave, delivering triple-digit gains in 2023-2024 and a solid 34% YTD rise in 2025. The thesis rests on AI data-center capex, which Nvidia says could reach $600B in 2025 and $3-4T by 2030, signaling a powerful long runway for GPU demand. Nvidia's model suggests it would capture a substantial slice of data-center spending (the firm notes roughly a $35B take on a $50B project), but revenue is lumpy as customers plan and deploy years in advance. If capex grows to $3.5T by 2030, the implied CAGR is around 42%, a driver for fiscal 2026 and beyond. The stock remains sensitive to AI progress, hyperscaler orders, and competitive dynamics.
Go toTop